Targeting synaptic dysfunction in Alzheimer's disease by administering a specific nutrient combination.
about
The effect of souvenaid on functional brain network organisation in patients with mild Alzheimer's disease: a randomised controlled studyNutrients required for phospholipid synthesis are lower in blood and cerebrospinal fluid in mild cognitive impairment and Alzheimer's disease dementia.Effects of Souvenaid on plasma micronutrient levels and fatty acid profiles in mild and mild-to-moderate Alzheimer's disease.Plasma 24-metabolite Panel Predicts Preclinical Transition to Clinical Stages of Alzheimer's DiseaseA Dietary Treatment Improves Cerebral Blood Flow and Brain Connectivity in Aging apoE4 MiceBrain health: the importance of recognizing cognitive impairment: an IAGG consensus conferenceA Specific Nutrient Combination Attenuates the Reduced Expression of PSD-95 in the Proximal Dendrites of Hippocampal Cell Body Layers in a Mouse Model of PhenylketonuriaDietary Crude Lecithin Increases Systemic Availability of Dietary Docosahexaenoic Acid with Combined Intake in Rats.Magnetoencephalography for the Detection of Intervention Effects of a Specific Nutrient Combination in Patients with Mild Alzheimer's Disease: Results from an Exploratory Double-Blind, Randomized, Controlled StudyEffect Size Analyses of Souvenaid in Patients with Alzheimer's Disease.The S-Connect study: results from a randomized, controlled trial of Souvenaid in mild-to-moderate Alzheimer's disease.The medical food Souvenaid affects brain phospholipid metabolism in mild Alzheimer's disease: results from a randomized controlled trial.Synaptic Membrane Synthesis in Rats Depends on Dietary Sufficiency of Vitamin C, Vitamin E, and Selenium: Relevance for Alzheimer's Disease.Methyl donor supplementation alters cognitive performance and motivation in female offspring from high-fat diet-fed dams.Omega-3 fatty acids, lipids and apoE lipidation in Alzheimer's disease: a rationale for multi-nutrient dementia prevention.Ethanolamine and Phosphatidylethanolamine: Partners in Health and Disease.Promising Effects of Neurorestorative Diets on Motor, Cognitive, and Gastrointestinal Dysfunction after Symptom Development in a Mouse Model of Parkinson's Disease.First translational 'Think Tank' on cerebrovascular disease, cognitive impairment and dementia.Lower brain and blood nutrient status in Alzheimer's disease: Results from meta-analysesDesign of the NL-ENIGMA study: Exploring the effect of Souvenaid on cerebral glucose metabolism in early Alzheimer's disease.24-month intervention with a specific multinutrient in people with prodromal Alzheimer's disease (LipiDiDiet): a randomised, double-blind, controlled trial.Systems healthcare: a holistic paradigm for tomorrow.Mediterranean diet, micronutrients and macronutrients, and MRI measures of cortical thickness.Thrombospondin-1 secreted by human umbilical cord blood-derived mesenchymal stem cells rescues neurons from synaptic dysfunction in Alzheimer's disease model.Status of nutrients important in brain function in phenylketonuria: a systematic review and meta-analysis.Additive Effects of Levodopa and a Neurorestorative Diet in a Mouse Model of Parkinson's Disease
P2860
Q28539196-8D73D732-4C94-490F-8084-FAA18C5F6F8CQ33813927-CE188662-FDA8-45E1-BF80-94E771033463Q35885375-C1FDC4AB-3349-44F8-BD0F-27A614B27919Q36272443-AADC21DA-09A6-4AA8-9136-7881E29D06B5Q36724664-D81856E1-01D2-4BB4-88F1-7B8B3B706672Q36770136-CB59E785-BEF7-4E8E-9AB3-47E20FF48E3EQ36846193-83A9E40C-111E-4388-B21E-66035E7368A5Q36994988-E7A7E190-97EC-468A-B07B-BEC036DD4F21Q37342482-5871117A-9043-40E9-A536-C52CFF796A5FQ37489106-BCE280F5-F6EF-481B-91FD-FF20C5F0B5C8Q37690572-4004ED62-1ABE-4B18-9B63-E4EDEDD16C88Q38659608-F818C42F-792B-44AF-955A-7AB73014416CQ38734121-724523F1-92F6-451B-AD7D-FF75CF0AEE89Q38956420-7EB40560-933C-406E-8003-6B96104AA9EBQ39320214-BC16D4FC-6F61-4D11-B122-FFBEF3EA9442Q41141822-C8143431-A535-410C-8B14-AA86BDC94544Q41916365-1AC986AC-E8DA-43D8-A4F4-C4883A61B5B0Q42568045-17D34E5C-ECF4-43AA-BB05-190951325F00Q42655692-2B8A199C-764F-4E8E-8DB2-B14F00543A32Q42656272-D5DEB2C8-AEB1-4E99-96D9-84B18C4811DBQ46105528-33C1BC66-43B1-4DF4-91B6-B378D49AA2F1Q47281739-C1C1FBBE-607B-475D-93D3-ABB43B3FC32BQ48601711-87FE9B1E-B281-42E9-B8E7-898747A36223Q49367941-69C4F76B-1A7E-4B2B-95CC-CBACFA6D5358Q55474071-1C0D5D92-C97C-4E5D-97D9-3E7A2F37AAA6Q58801455-D7CEEC04-BB18-4B6A-94B9-0E57B651E0C4
P2860
Targeting synaptic dysfunction in Alzheimer's disease by administering a specific nutrient combination.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Targeting synaptic dysfunction ...... specific nutrient combination.
@en
type
label
Targeting synaptic dysfunction ...... specific nutrient combination.
@en
prefLabel
Targeting synaptic dysfunction ...... specific nutrient combination.
@en
P2093
P356
P1476
Targeting synaptic dysfunction ...... specific nutrient combination
@en
P2093
John W C Sijben
Laus M Broersen
Martijn C de Wilde
Martine Groenendijk
Patrick J G H Kamphuis
Robert J J Hageman
P304
P356
10.3233/JAD-130998
P577
2014-01-01T00:00:00Z